Millennium Management »

Global X Fds genomic biotech shares owned by Millennium Management

Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Global X Fds genomic biotech

Tip: Access up to 7 years of quarterly data

All positions including Global X Fds genomic biotech held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Global X Fds genomic biotech by Millennium Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $123k 11k 11.56

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors Put Option (TSLA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices Call Option (AMD)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Broadcom (AVGO)

View all positions for Millennium Management

Top funds holding Global X Fds genomic biotech

One Capital Management
Mirae Asset Global Investments
Lido Advisors
Raymond James Financial Services Advisors
Portland Global Advisors
UBS Group
Stratos Wealth Partners
Sightline Wealth Advisors
Oppenheimer Asset Management
McGuire Investment Group
Berson & Corrado Investment Advisors
LPL Financial
Jane Street
Royal Bank of Canada
Bank of America Corporation

View all funds holding Global X Fds genomic biotech